Clostridial spores as live 'Trojan horse' vectors for cancer gene therapy: comparison with viral delivery systems
2008

Clostridial Spores as Cancer Gene Therapy Vectors

publication Evidence: moderate

Author Information

Author(s): Wei Ming Q, Ren Ruimei, Good David, Anné Jozef

Hypothesis

Can clostridial spores serve as effective 'Trojan horse' vectors for cancer gene therapy compared to viral delivery systems?

Conclusion

Clostridial spores have shown potential as effective vectors for cancer gene therapy, outperforming traditional viral systems in certain aspects.

Supporting Evidence

  • Clostridial spores can selectively colonize and germinate in solid tumors.
  • They can be genetically modified to enhance their tumor-killing capabilities.
  • Clostridial spores have shown a high percentage of 'cures' in experimental tumor models.

Takeaway

Clostridial spores can help deliver cancer-fighting genes directly to tumors, making them a promising new treatment option.

Methodology

The review discusses various gene therapy vector systems, focusing on the advantages of clostridial spores in targeting solid tumors.

Limitations

The efficacy of clostridial spores in achieving significant tumor regression has been inconsistent, and further research is needed to optimize their use.

Digital Object Identifier (DOI)

10.1186/1479-0556-6-8

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication